Related Experiment Videos
Lifetime risk for cardiovascular disease in a Chinese population: the Chinese Multi-Provincial Cohort Study
Ying Wang1, Jing Liu1, Wei Wang1
1Department of Epidemiology, Capital Medical University Beijing Anzhen Hospital-Beijing Institute of Heart, Lung & Blood Vessel Diseases, Beijing, China.
Insights
Lifetime cardiovascular disease (CVD) risk is higher in Chinese men than women. Optimizing risk factors significantly reduces lifetime CVD risk, highlighting the importance of early prevention strategies.
Area of Science:
- Epidemiology
- Cardiovascular Health
- Public Health
Background:
- Lifetime risk estimation for cardiovascular disease (CVD) traditionally relies on Western population data.
- There is a need to assess CVD lifetime risk and the influence of risk factors specifically within the Chinese population.
Purpose of the Study:
- To evaluate the lifetime risk of cardiovascular disease (CVD) in the Chinese population.
- To determine the impact of various risk factors on the lifetime risk of CVD in this demographic.
Main Methods:
- A prospective, population-based cohort study design was employed.
- Data from 21,953 participants (aged 35-84) without baseline CVD were analyzed from the Chinese Multi-Provincial Cohort Study (CMCS).
- The modified Kaplan-Meier method was utilized for lifetime CVD risk calculation.
Main Results:
- Lifetime CVD risk up to age 80 for 35-year-old men and women was 24.4% and 20.2%, respectively.
- Individuals with an optimal risk factor profile exhibited a significantly lower lifetime risk, mitigating aging effects.
- Conversely, those with two or more high-risk factors faced a substantially elevated lifetime risk (men: 51.1%, women: 38.6% by age 80).
Conclusions:
- The cumulative status of major CVD risk factors is a key determinant of long-term cardiovascular health and disease risk in China.
- Aggressive, early-stage prevention focusing on optimizing all risk factors is crucial for future CVD prevention efforts.
- Findings underscore the need for culturally specific CVD risk assessment and intervention strategies.
Background:
Lifetime risk estimation is used to predict long-term cardiovascular disease (CVD) risk across the entire life span. However, most of the lifetime risk estimation came from the studies based on western population. This study aimed to assess the lifetime risk of CVD and the impact of risk factors on lifetime risk of CVD in Chinese population.
Design:
Prospective population-based cohort study.
Methods:
The study sample came from the Chinese Multi-Provincial Cohort Study (CMCS), 21,953 participants aged 35 to 84 years without CVD at the baseline were included. The modified Kaplan-Meier method was used to calculate the lifetime risk of CVD.
Results And Conclusions:
During follow-up years from 1992 to 2010, 1,280 participants developed acute CVD events and 1,401 died. The lifetime CVD risk, up to age 80 for men and women at age 35, were 24.4% and 20.2% respectively. A very low lifetime risk was found in individuals with an optimal profile of risk factors which modified the effect of aging. By contrast, with two or more high risk factors the lifetime risk up to age 80 reached 51.1% for men and 38.6% for women at age 35. The integrated status of major CVD risk factors can determine lifetime cardiovascular health and CVD risk in Chinese. Early prevention with a goal of all risk factors at optimal levels should become the priority of CVD prevention in the future.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Relative Risk
Coronary Artery Disease II: Pathophysiology
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...